Intelligent Nanocellulose-Based Medical Implant Systems

Publication ID: 24-11857405_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Nanocellulose-Based Medical Implant Systems,” Published Technical Disclosure No. 24-11857405_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857405_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,405.

Summary of the Inventive Concept

The present inventive concept integrates nanocellulose-based medical implants with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to create novel, high-performance systems for bile duct repair and other medical applications.

Background and Problem Solved

The original patent for a medical implant based on nanocellulose addressed the critical issue of bile duct reconstruction in hepato-biliary surgery. However, the original invention had limitations in terms of implant customization, placement optimization, and post-operative monitoring. The new inventive concept overcomes these limitations by synergistically combining the nanocellulose-based implant with AI-powered surgical planning, IoT-enabled sensors, blockchain-based tracking, and advanced materials.

Detailed Description of the Inventive Concept

The inventive concept comprises a nanocellulose-based medical implant produced using a microbial cellulose tube, which is integrated with one or more of the following technologies: an AI-powered surgical planning module for optimizing implant placement; machine learning algorithms for generating customized implant designs based on patient-specific data; an IoT-enabled sensor for monitoring implant performance and detecting potential complications; a blockchain-based decentralized ledger for recording and verifying implant production, distribution, and usage; and a composite material incorporating the nanocellulose-based matrix with reinforcing materials like graphene, carbon nanotubes, or metal nanoparticles.

Novelty and Inventive Step

The new claims introduce a novel combination of the nanocellulose-based implant with distinct technologies, resulting in a synergistic system that provides improved performance, customization, and monitoring capabilities. The inventive step lies in the integration of these technologies to create a more powerful and effective system for bile duct repair and other medical applications.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms for surgical planning, varying types of IoT sensors for implant monitoring, or alternative blockchain platforms for tracking and verification. Additionally, the nanocellulose-based matrix could be combined with other reinforcing materials or used in conjunction with other medical implant technologies.

Potential Commercial Applications and Market

The intelligent nanocellulose-based medical implant systems have significant commercial potential in the medical device industry, particularly in the areas of hepato-biliary surgery, tissue engineering, and personalized medicine. The target market includes hospitals, research institutions, and medical device manufacturers seeking innovative solutions for complex medical procedures.

CPC Classifications

SectionClassGroup
A A61 A61F2/04
A A61 A61L31/005
A A61 A61L31/10
A A61 A61L31/146
A A61 A61F2002/041
A A61 A61L2400/12
A A61 A61L2420/08
C C08 C08L1/02

Original Patent Information

Patent NumberUS 11,857,405
TitleMedical implant based on nanocellulose
Assignee(s)UNIVERSITÄTSKLINIKUM JENA